Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 4/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.48 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL6694801 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL6694808 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL6694805 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL3796267 | 0.97 | SLC22A1 (0.71) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL20485063 | 0.84 | SLC22A1 (0.52) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL27257891 | 0.83 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL1073228 | 0.83 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrapropylammonium SCHEMBL6686604 | 0.82 | SLC22A1 (0.62) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL6949325 | 0.82 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL5724808 | 0.82 | SLC22A1 (0.86) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116178693-B | Preparation method for catalyzing copolymerization of carbon dioxide and propylene oxide by using azoimidazole modified Mn-Mg nanocluster | 安徽大学 | 2025-02-14 | — | — | CN | claimed |
| US-20240409431-A1 | Metal Oxide having Spinel-Type Crystal Structure, Method for Producing Same, Carbon Dioxide Reduction Method, and Carbon Dioxide Reduction Apparatus | TOHOKU UNIVERSITY (JP) | 2024-12-12 | — | — | US | claimed |
| WO-2024177133-A1 | MANGANESE DIOXIDE, POLYVALENT METAL ION SECONDARY BATTERY USING SAME, AND METHODS FOR MANUFACTURING SAME | 国立大学法人北海道大学 | 2024-08-29 | — | — | WO | claimed |
| EP-4414330-A1 | METAL OXIDE HAVING SPINEL-TYPE CRYSTAL STRUCTURE, METHOD FOR PRODUCING SAME, CARBON DIOXIDE REDUCTION METHOD, AND CARBON DIOXIDE REDUCTION APPARATUS | Tohoku University (JP) | 2024-08-14 | — | — | EP | claimed |
| CN-118019716-A | Metal oxide having spinel-type crystal structure, method for producing same, method for reducing carbon dioxide, and carbon dioxide reduction device | 国立大学法人东北大学 | 2024-05-10 | — | — | CN | claimed |
| CN-116178693-A | Preparation method for catalyzing copolymerization of carbon dioxide and propylene oxide by using azoimidazole modified Mn-Mg nanocluster | 安徽大学 | 2023-05-30 | — | — | CN | claimed |
| WO-2023058182-A1 | METAL OXIDE HAVING SPINEL-TYPE CRYSTAL STRUCTURE, METHOD FOR PRODUCING SAME, CARBON DIOXIDE REDUCTION METHOD, AND CARBON DIOXIDE REDUCTION APPARATUS | 国立大学法人東北大学 | 2023-04-13 | — | — | WO | claimed |
| CN-115850257-A | Synthetic method of emodin amide derivatives containing coumarin thiazole and application of emodin amide derivatives in resisting marine vibrio | 江苏海洋大学 | 2023-03-28 | — | — | CN | claimed |
| CN-112480031-B | Emodin amide derivatives containing 1,3, 4-thiadiazole, and synthesis method and application thereof | 江苏海洋大学 | 2022-05-20 | — | — | CN | claimed |
| CN-112480031-A | Emodin amide derivatives containing 1,3, 4-thiadiazole, and synthesis method and application thereof | 江苏海洋大学 | 2021-03-12 | — | — | CN | claimed |
| WO-2017044896-A1 | BIOMEDICAL ADHESIVE AND SEALANT COMPOSITIONS AND METHODS OF USE | DSM IP ASSETS B.V. (NL) | 2017-03-16 | — | — | WO | claimed |
| CN-104761591-A | Mn4CaO4 core structure-containing water cracking catalyst and preparation method and application thereof | CHINESE ACAD INST CHEMISTRY | 2015-07-08 | — | — | CN | claimed |
| US-8026200-B2 | Low pH mixtures for the removal of high density implanted resist | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2011-09-27 | — | — | US | claimed |
| EP-2288965-A2 | LOW PH MIXTURES FOR THE REMOVAL OF HIGH DENSITY IMPLANTED RESIST | Advanced Technology Materials, Inc. (US) | 2011-03-02 | — | — | EP | claimed |
| US-20090281016-A1 | LOW pH MIXTURES FOR THE REMOVAL OF HIGH DENSITY IMPLANTED RESIST | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2009-11-12 | — | — | US | claimed |
| WO-2009135102-A2 | LOW PH MIXTURES FOR THE REMOVAL OF HIGH DENSITY IMPLANTED RESIST | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2009-11-05 | — | — | WO | claimed |
| CN-101570486-A | Method for preparing anomalous methyl ent-isocopalate | UNIV EAST CHINA SCIENCE & TECH (CN) | 2009-11-04 | — | — | CN | claimed |
| WO-2007118711-A1 | 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-10-25 | — | — | WO | claimed |
| US-20070249573-A1 | 17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-10-25 | — | — | US | claimed |
| US-5288834-A | Brominated chemical intermediate | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 1994-02-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249573-A1 | 17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production | CYP19A1, HSD17B11, CYP2A13 | SLC22A1 2422/4885SLC22A2 2629/4885ALDH1A1 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.